US Stock MarketDetailed Quotes
CYTH Cyclo Therapeutics
- 1.448
- +0.188+14.88%
Trading Apr 29 15:35 ET
41.57MMarket Cap-1176P/E (TTM)
1.470High1.283Low47.14KVolume1.320Open1.260Pre Close66.25KTurnover0.30%Turnover RatioLossP/E (Static)28.72MShares2.57052wk High8.72P/B22.96MFloat Cap0.89252wk Low--Dividend TTM15.87MShs Float17.750Historical High--Div YieldTTM14.83%Amplitude0.670Historical Low1.405Avg Price1Lot Size
Cyclo Therapeutics News
Cyclo Therapeutics Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Cyclo Therapeutics (CYTH), CytomX Therapeutics (CTMX) and Pacific Biosciences (PACB)
Buy Rating Affirmed for Cyclo Therapeutics on Strong Clinical and Financial Prospects
Cyclo Therapeutics Analyst Ratings
Cyclo Therapeutics (CYTH) Receives a Buy from Maxim Group
No More
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg